Cargando…

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma

BACKGROUND: Cell division cycle associated 2 (CDCA2), a member of the cell division cycle associated proteins (CDCA) family, is crucial in the regulation of cell mitosis and DNA repair. CDCA2 was extensively examined in our work to determine its role in a wide range of cancers. METHODS: CDCA2 differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenle, Lv, Dong, Yao, Jieqin, Chen, Boxian, Liu, Huanqiang, Li, Wensheng, Xu, Chengjie, Li, Zhenzhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513342/ https://www.ncbi.nlm.nih.gov/pubmed/37733705 http://dx.doi.org/10.1371/journal.pone.0291024

Ejemplares similares

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

An in silico approach to the identification of diagnostic and prognostic markers in low-grade gliomas
por: Özbek, Melih, et al.
Publicado: (2023)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2021)

KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2023)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
por: He, Ya, et al.
Publicado: (2022)

Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma
por: Su, Xiaotao, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
por: Fang, Hui, et al.
Publicado: (2022)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma
por: Wang, Haiwei, et al.
Publicado: (2021)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

Structuring and validating a prognostic model for low-grade gliomas based on the genes for plasma membrane tension
por: Li, Jia, et al.
Publicado: (2022)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
por: Wang, Xiaoxiong, et al.
Publicado: (2021)

Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma
por: Sun, Jingxian, et al.
Publicado: (2021)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study
por: Liu, Jieting, et al.
Publicado: (2021)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

Prognostic value of magnetic resonance imaging features in low-grade gliomas
por: Deng, Liang, et al.
Publicado: (2019)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Expression and prognostic characteristics of m(5)C regulators in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021)

NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis
por: Ju, Qiang, et al.
Publicado: (2020)

Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment
por: Lu, Xiuqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjiregd1tj0rbi0gsouoei1osr